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A single step immunoaffinity purification procedure for human erythrocyte acetylcholinesterase i  described which per- 
mitted the isolation of milligram quantities of enzyme from 10 U of erythrocytes, with 113 000-fold purification and 
a yield of about 22%. In SDS-PAGE analysis, the enzyme corresponds to a disulfide linked dimer of 140 kDa which 
is converted to a 70 kDa monomer upon disultide reduction. The tryptic peptides generated from purified enzyme were 
separated by reverse-phase HPLC. Five of these peptides were analysed to determine the amino acid sequences. The ob- 
tained sequences showed no homology to the already known amino acid sequences for human serum and brain butyryl- 
cholinesterase and Torpedo californica cetylcholinesterase. 
Acetylcholinesterase; ImmunoatEnity chromatography; Amino acid sequence 
1. INTRODUCTION 
Acetylcholinesterase (AChE), an essential en- 
zyme of the nervous system, rapidly terminates the 
action of acetylcholine released into the synapse. 
The enzyme exists in multiple molecular forms [l] 
with similar kinetic properties. The asymmetric 
and globular forms differ in their cellular localiza- 
tion [l], in number of catalytic subunits [2], in 
level of hydrophobicity [3] and mode of glycosyla- 
tion [4]. In blood, amphipathic acetylcholinester- 
ase dimers of globular form are bound to the 
erythrocyte membrane [5,6]. The present study 
was undertaken to determine the partial amino 
acid sequence for human erythrocyte acetylcholi- 
nesterase, which can further be used for isolating 
the gene of the enzyme, as no such information is 
available to date. Attempts to identify the gene for 
human acetylcholinesterase using the probes de- 
rived from the Torpedo enzyme cDNA sequence 
[7] have resulted in the isolation of genes for 
pseudocholinesterase [8]. 
Correspondence address: V. Chhajlani, Department of Phar- 
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2. MATERIALS AND METHODS 
2.1. Extraction of acetylcholinesterase from human 
erythrocytes 
Packed human erythrocytes from lo- to 20-day-old collection 
of blood obtained from Baltimore Red Cross blood program 
(Baltimore, MD, USA) were washed three times with a cold, 
isotonic solution of 5 mM sodium phosphate, pH 7.5, contain- 
ing 0.15 M sodium chloride. The cells were then lysed by slowly 
pouring and stirring into 20 vols of cold lysis buffer (5 mM 
sodium phosphate, pH 7.5, containing 0.02% sodium azide). 
The erythrocyte membranes were separated from soluble pio- 
teins and simultaneously concentrated to approx. 2 1 using 
Millipore pellicon high volume molecular filtration set-up as 
described [9]. The membranes were then washed with 20 1 of 
cold lysis buffer using the above mentioned set-up and collected 
by centrifugation at 4°C for 30 min at 10000 x g. The proteins 
of the washed membranes were solubilized by adding Triton 
X-100 to a final concentration of 1% and stirring the mixture 
for 15 h at 4°C. The supernatant fluid was collected by cen- 
trifugation at 100000 x g for 1 h at 4°C and then diluted 5-fold 
by adding 4 vols of lysis buffer before loading onto the 
monoclonal antibody affinity column. 
2.2. Monoclonal antibody affinity column preparation 
Hybridoma cells secreting monoclonal antibody AE-4, 
specific for human acetylcholinesterase, were obtained from Dr 
D. Fambrough (Carnegie Institute, Baltimore, MD, USA) [lo]. 
Large amounts of immunoglobulin were obtained by growing 
cells as ascites tumors in mice. Ascites fluid was inactivated at 
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56°C for 30 min and clarified by centrifugation at 100000 x g 
for 1 h. The antibody was purified from ascites fluid by 
chromr+tography on a protein A-Sepharose column (data not 
shown). The purified IgG was coupled to Sepharose CL-4B ac- 
cording to the procedure described [ll]. A 1.5 x 10 cm column 
containing 30 mg of AE-4 antibody coupled to 10 ml of 
Sepharose CL-4B beads was washed with several volumes of 
20 mM sodium phosphate buffer, pH 7.5, before applying the 
erythrocyte membrane xtract. 
2.3. Purification of acetylcholinesterase 
The diluted extract was loaded onto the AE-4 antibody affini- 
ty column at a flow rate of 1 ml/min, at 4°C. After the sample 
was loaded, column was washed successively with 30 ml each of 
(i) 20 mM sodium phosphate, pH 7.5, containing 0.2070 Triton 
X-100, (ii) 20 mM sodium phosphate, pH 7.5, containing 0.5% 
P-D-octylglucoside, (iii) 0.1 M borate buffer, pH 8.0, contain- 
ing 1 M sodium chloride and 0.5% ,%D-octylglucoside, (iv) 
50 mM diethylamine, pH 10.0, with 0.5% fl-D-octylglucoside. 
The protein was then eluted with 50 mM diethylamine, pH 
10.5, containing 0.5% #I-D-octylglucoside. Fractions of 3 ml 
were collected in tubes containing 0.5 ml of 0.5 M monobasic 
sodium phosphate with 0.5% fi-D-octylglucoside. Individual 
fractions were assayed for enzyme activity according to Ellman 
et al. [12]. The active fractions were pooled and concentrated 
to 1 ml by vacuum dialysis against 100 mM sodium phosphate, 
pH 8.0, containing 0.5% P-D-octylglucoside. Protein concen- 
tration was determined as described in [13]. 
2.4. Enzyme assay 
Acetylcholinesterase activity was estimated according to 
Ellman et al. [12]. The assay mixture contained 5 ,ul of 50 mM 
dithiobisnitrobenzoic acid, 5 ~1 enzyme sample, 300~1 of 
100 mM sodium phosphate buffer, pH 7.5, and 2 /tl of 75 mM 
acetylthiocholine substrate. Appearance of the nitrothiobenzoic 
acid adduct of thiocholine product was measured spec- 
trophotometrically at several time points as the increase in ab- 
sorbance at 405 nm. 
Fig. 1. SDS-PAGE analysis for purified AChE (20 cg) before (a) 
and after disulfide reduction (b). The molecular mass was 
calculated as described in the text. 
2.5. SDS-PAGE analysis 
Vertical, 10% polyacrylamide slab gel was prepared and run 
according to the system described by Laemmli [14]. The gels 
were stained with silver nitrate for protein visualization [15]. 
The molecular mass for the purified AChE was estimated from 
standard curve of log kDa versus relative migration of polypep- 
tide standards. 
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Table 1 
Purification of human erythrocyte acetylcholinesterasea 
Step Total Total ActivityC Recovery Specific Fold 
volume proteinb (AA/min)d (percent) activity purification 
(ml) (mg) (AA/min per mg) 
Hemolysate 21217 488286 292971 0.6 1 
Red cell ghosts 1132 5040 262 080 89 52 486 
1OOOOOxg 
supernatant 1027 994 176932 60 178 296 
Antibody affinity 0.9 0.95 64771 22 68 180 113633 
a Results are the mean value of four purifications 
b Protein was measured as described in [13] 
’ Enzyme activity was measured as described in [12] 
* Change in absorbance at 405 nm 
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2.6. Trypsin digestion of acetykholinesterase and separation of 
peptides 
Purified enzyme (70 pg in 2 ml of 20 mM sodium phosphate 
buffer, pH 7.6, containing 0.2% &D-octylglucoside) was in- 
cubated twice with 1.5 pg trypsin at room temperature for 4 h 
each. The peptide mixture was applied to a Vydac reverse-phase 
C4 column (4.6 mm x 25 cm) equipped with a Beckman 421 
gradient controller. The solvents were (A) 0.1% trifluoroacetic 
acid (TFA) and (B) acetonitrile propanol(2: 1) containing 0.1% 
TFA. The column temperature was maintained at 45°C. The 
peptides were eluted at a flow rate of 1 ml/min with the gra- 
dient program shown in fig.2. 
2.7. Amino acid sequence analysis 
Individual peptide peaks from reverse-phase HPLC were 
dried under vacuum, redissolved in 100~1 of 50% acetic acid 
(aldehyde free) and analysed with an Applied Biosystems model 
470 A gas-phase sequencer with an on-line PTH-amino acid 
analyser. 
3. RESULTS AND DISCUSSION 
3.1. Purijkation of erythrocyte acetylcholin- 
esterase 
The results of a typical purification experiment 
are summarized in table 1. 1 mg of pure enzyme 
could be obtained from 10 U of packed 
erythrocytes. This yield is similar to that reported 
by Rosenberry et al. [5], using the acridinium 
ligand procedure. The recovery of the enzyme ac- 
tivity was found to be 22% with a fold purification 
of over 113000. The Triton X-100 used to 
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solubilize the enzyme was displaced during affinity 
chromatography by another detergent P-D- 
octylglucoside, which could be easily dialysed and 
did not interfere with the separation of peptides on 
reverse-phase HPLC. The elution of enzyme from 
the antibody column at pH 10.5 was found to be 
important as the enzyme eluted at higher pH values 
was partially denatured and less active (data not 
shown). 
The preparation was found to be homogeneous 
by SDS-PAGE analysis (fig.1). The enzyme was 
present as a dimer (140 kDa) before and as a 
monomer (70 kDa) after disulfide reduction. 
3.2. Fractionation of tryptic peptides and amino 
acid sequence analysis 
Fig.2 shows the elution profile obtained by 
reverse-phase HPLC of the tryptic peptides of 
acetylcholinesterase. Identical profiles were ob- 
tained for the peptide mixtures in three separate 
experiments. Approx. 19 peptides were resolved. 
Five of these peptides have yielded satisfactory se- 
quence data (table 2), totaling for 105 residues. 
The sequences obtained show no homology with 
the human butyrylcholinesterase [8] or Torpedo 
acetylcholinesterase [7]. The erythrocyte acetyl- 
cholinesterase being globular in nature is expected 
to be different than the asymmetric form of the en- 
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Fig.2. Preparation of tryptic peptides of AChE. AChE (70~~) in 2 ml of 20 mM sodium phosphate, pH 7.6, containing 0.20m 
octylglucoside was treated at room temperature for 8 h with a total of 3 fig of trypsin. The digest was applied to a Vydac C4 column 
(4.6 mm x 25 cm), maintained at 45°C. The solvents were (A) 0.1% TFA and (B) acetonitrile/propano1(2 : 1) containing 0.1% TFA. 
The peptides were eluted at a flow rate of 1 ml/min with the following gradient program: Oslo B for 5 min, 0% B to 55% B in 75 min, 
55% B to 100% B in 10 min and 100% B for 10 min. The peptides are numbered in their order of elution from the column. 
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Table 2 
Sequence analysis of AChE tryptic peptides 
Cycle 
number 
Peptide 7 Peptide 9 Peptide 10 Peptide 11 Peptide 16 
Amino Yield Amino Yield Amino Yield Amino Yield Amino Yield 
acid (pmol) acid (pmol) acid (pmol) acid (pmol) acid (pmol) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
Average repetitive 
yield 
Ala 
Val 
Leu 
Gln 
Ser 
Gly 
Ala 
Pro 
Asn 
Gly 
Pro 
Try 
Ala 
Thr 
Val 
Gly 
Met 
Gly 
X 
224 
265 
188 
56 
129 
176 
190 
85 
124 
131 
46 
103 
35 
82 
101 
74 
44 
Thr 99 
Arg 50 
Pro 210 
X X 
Gln 73 
Val 118 
Leu 113 
Val 118 
X X 
His 25 
Glu 71 
Asp 64 
His 25 
Val 85 
Leu 94 
Pro 98 
Gln 48 
GlU 50 
Asp 59 
Val 20 
Phe 45 
X X 
Pro 276 
Gln 116 
Try 156 
Pro 218 
Pro 225 
Tyr 144 
Thr 71 
Ala 158 
Gly 141 
Ala 101 
Gln 132 
Gln 122 
Tyr 116 
Val 125 
Ser 26 
Leu 93 
Asp 36 
Leu 75 
Arg 34 
Pro 85 
Leu 63 
Glu 48 
Val 49 
Val 216 .X X 
Gly 142 X X 
Val 202 Thr 28 
Pro 296 Leu 75 
Gln 119 Asp 32 
Val 182 Val 19 
Ser 40 Pro 49 
Asp 56 Leu 50 
Leu 160 X X 
Ala 117 Met 36 
Ala 126 Gly 27 
Glu 92 Val 33 
Ala 106 Pro 37 
Val 110 X X 
Val 92 Gly 25 
Leu 115 Tyr 15 
Asp 22 
Tyr 73 
Thr 29 
Asp 29 
Try 36 
Leu 64 
X X 
Pro 60 
X X 
Asp 16 
Pro 46 
88.35 88 89.7 95.2 86 
X, unidentified residue 
zyme, the gene for which is cloned from Torpedo 
californica [7]. We are now using the obtained 
amino acid sequences to generate the 
oligonucleotide probes and identify the gene for 
human erythrocyte acetylcholinesterase. 
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